Results 101 to 110 of about 1,399,448 (251)
Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro
Proton pump inhibitors (PPIs) are commonly prescribed drugs that decrease stomach acidity and are thus often used to treat gastroesophageal reflux disease and as a preventative agent for the adverse effects of nonsteroidal anti-inflammatory drugs on the ...
Markus Prause +5 more
doaj +1 more source
[A&T]MLN is a triple‐modal nanoplatform with siRNA‐loaded LN coated with hybrid ACE2/macrophage membrane. It blocks viral entry, neutralizes IL‐6/IL‐1β/TNF‐α, and delivers siRNA to suppress viral replication. In a murine lung injury model, it attenuates inflammation, offering a multi‐pronged strategy against SARS‐CoV‐2 variants and hyperinflammation ...
Hui Li +19 more
wiley +1 more source
Usage of intravenous forms of proton pump inhibitors
Background: Upper gastrointestinal tract bleeding is a common clinical problem. However, there are no clear international guidelines for its management.
Marijan Ivanuša
doaj
A bioactive poly(citrate‐polyglycol‐procyanidin) (PCGP) nanoshield is developed for cardiovascular implants to restore endothelial mitochondrial homeostasis following vascular injury. By preserving mitochondrial integrity, re‐establishing metabolic balance, and activating PI3K/Akt/eNOS‐NO signaling, the PCGP interface promotes functional endothelial ...
Xiyu Liu +14 more
wiley +1 more source
Background Combining immune checkpoint and proton pump inhibitors is widely used in cancer treatment. However, the drug-drug interactions of these substances are currently unknown.
Xiayang Ren +5 more
doaj +1 more source
Proton Pump Inhibitors Pharmacokinetic Properties and Therapeutic Effectiveness
The theses discuss on the mechanism of action of Proton Pump Inhibitors, also the pharmacokinetical properties e.g structure, entry root, absorption, distribution, protein binding, metabolism and clearance.
Yarden, Yonovich
core
A carrier‐free zinc‐coordinated polyphenol nanoplatform (ZnCA NPs) is designed as an “all‐in‐one” therapeutic strategy for intestinal inflammation. The ZnCA NPs exhibit enhanced colonic accumulation and broad‐spectrum reactive oxygen and nitrogen species scavenging.
Qiwen Xie +7 more
wiley +1 more source
A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy
We describe the clinical scenario of a young male with history of non ulcer dyspepsia who had endoscopic evidence of gastric polyposis in antral area. The polyps disappeared four months after proton pump inhibitors were stopped.
Alqutub, Adel Nazmi +3 more
core +1 more source
Acidic CO2 electroreduction to formic acid is enabled by integrating mixed Sn/SnOx nanoclusters, K+‐regulated interfacial solvation, and Janus wettability. Coordinated control of active sites, interfacial water, and gas‐liquid transport suppresses hydrogen evolution and delivers approximately 85% HCOOH Faradaic efficiency at 400 mA cm−2.
Qiaoqi Guo +8 more
wiley +1 more source
Aim: to compare the efficacy of proton pump inhibitors and potassium-competitive acid blockers (P-CABs) in achieving and maintaining endoscopic remission in erosive gastroesophageal reflux disease.Materials and methods.
P. G. Ermishina +5 more
doaj +1 more source

